263 related articles for article (PubMed ID: 25391896)
1. A novel vaccinia virus with dual oncolytic and anti-angiogenic therapeutic effects against triple-negative breast cancer.
Gholami S; Marano A; Chen NG; Aguilar RJ; Frentzen A; Chen CH; Lou E; Fujisawa S; Eveno C; Belin L; Zanzonico P; Szalay A; Fong Y
Breast Cancer Res Treat; 2014 Dec; 148(3):489-99. PubMed ID: 25391896
[TBL] [Abstract][Full Text] [Related]
2. Combination of fractionated irradiation with anti-VEGF expressing vaccinia virus therapy enhances tumor control by simultaneous radiosensitization of tumor associated endothelium.
Buckel L; Advani SJ; Frentzen A; Zhang Q; Yu YA; Chen NG; Ehrig K; Stritzker J; Mundt AJ; Szalay AA
Int J Cancer; 2013 Dec; 133(12):2989-99. PubMed ID: 23729266
[TBL] [Abstract][Full Text] [Related]
3. Preclinical Testing Oncolytic Vaccinia Virus Strain GLV-5b451 Expressing an Anti-VEGF Single-Chain Antibody for Canine Cancer Therapy.
Adelfinger M; Bessler S; Frentzen A; Cecil A; Langbein-Laugwitz J; Gentschev I; Szalay AA
Viruses; 2015 Jul; 7(7):4075-92. PubMed ID: 26205404
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of a new recombinant oncolytic vaccinia virus strain GLV-5b451 for feline mammary carcinoma therapy.
Adelfinger M; Gentschev I; Grimm de Guibert J; Weibel S; Langbein-Laugwitz J; Härtl B; Murua Escobar H; Nolte I; Chen NG; Aguilar RJ; Yu YA; Zhang Q; Frentzen A; Szalay AA
PLoS One; 2014; 9(8):e104337. PubMed ID: 25093734
[TBL] [Abstract][Full Text] [Related]
5. Virotherapy of canine tumors with oncolytic vaccinia virus GLV-1h109 expressing an anti-VEGF single-chain antibody.
Patil SS; Gentschev I; Adelfinger M; Donat U; Hess M; Weibel S; Nolte I; Frentzen A; Szalay AA
PLoS One; 2012; 7(10):e47472. PubMed ID: 23091626
[TBL] [Abstract][Full Text] [Related]
6. Vaccinia virus GLV-1h153 is effective in treating and preventing metastatic triple-negative breast cancer.
Gholami S; Chen CH; Lou E; De Brot M; Fujisawa S; Chen NG; Szalay AA; Fong Y
Ann Surg; 2012 Sep; 256(3):437-45. PubMed ID: 22868370
[TBL] [Abstract][Full Text] [Related]
7. Gene therapy using therapeutic and diagnostic recombinant oncolytic vaccinia virus GLV-1h153 for management of colorectal peritoneal carcinomatosis.
Eveno C; Mojica K; Ady JW; Thorek DL; Longo V; Belin LJ; Gholami S; Johnsen C; Zanzonico P; Chen N; Yu T; Szalay AA; Fong Y
Surgery; 2015 Feb; 157(2):331-7. PubMed ID: 25616946
[TBL] [Abstract][Full Text] [Related]
8. Growth inhibition of different human colorectal cancer xenografts after a single intravenous injection of oncolytic vaccinia virus GLV-1h68.
Ehrig K; Kilinc MO; Chen NG; Stritzker J; Buckel L; Zhang Q; Szalay AA
J Transl Med; 2013 Mar; 11():79. PubMed ID: 23531320
[TBL] [Abstract][Full Text] [Related]
9. A novel genetically modified oncolytic vaccinia virus in experimental models is effective against a wide range of human cancers.
Haddad D; Chen N; Zhang Q; Chen CH; Yu YA; Gonzalez L; Aguilar J; Li P; Wong J; Szalay AA; Fong Y
Ann Surg Oncol; 2012 Jul; 19 Suppl 3():S665-74. PubMed ID: 22258815
[TBL] [Abstract][Full Text] [Related]
10. Anti-VEGF single-chain antibody GLAF-1 encoded by oncolytic vaccinia virus significantly enhances antitumor therapy.
Frentzen A; Yu YA; Chen N; Zhang Q; Weibel S; Raab V; Szalay AA
Proc Natl Acad Sci U S A; 2009 Aug; 106(31):12915-20. PubMed ID: 19617539
[TBL] [Abstract][Full Text] [Related]
11. Oncolytic gene therapy with recombinant vaccinia strain GLV-2b372 efficiently kills hepatocellular carcinoma.
Ady JW; Johnsen C; Mojica K; Heffner J; Love D; Pugalenthi A; Belin LJ; Chen NG; Yu YA; Szalay AA; Fong Y
Surgery; 2015 Aug; 158(2):331-8. PubMed ID: 26049609
[TBL] [Abstract][Full Text] [Related]
12. A novel oncolytic viral therapy and imaging technique for gastric cancer using a genetically engineered vaccinia virus carrying the human sodium iodide symporter.
Jun KH; Gholami S; Song TJ; Au J; Haddad D; Carson J; Chen CH; Mojica K; Zanzonico P; Chen NG; Zhang Q; Szalay A; Fong Y
J Exp Clin Cancer Res; 2014 Jan; 33(1):2. PubMed ID: 24383569
[TBL] [Abstract][Full Text] [Related]
13. Replication efficiency of oncolytic vaccinia virus in cell cultures prognosticates the virulence and antitumor efficacy in mice.
Chen NG; Yu YA; Zhang Q; Szalay AA
J Transl Med; 2011 Sep; 9():164. PubMed ID: 21951588
[TBL] [Abstract][Full Text] [Related]
14. Recombinant vaccinia virus GLV-1h68 is a promising oncolytic vector in the treatment of cholangiocarcinoma.
Pugalenthi A; Mojica K; Ady JW; Johnsen C; Love D; Chen NG; Aguilar RJ; Szalay AA; Fong Y
Cancer Gene Ther; 2015 Dec; 22(12):591-6. PubMed ID: 26584530
[TBL] [Abstract][Full Text] [Related]
15. Vaccinia virus GLV-1h153 in combination with 131I shows increased efficiency in treating triple-negative breast cancer.
Gholami S; Chen CH; Lou E; Belin LJ; Fujisawa S; Longo VA; Chen NG; Gönen M; Zanzonico PB; Szalay AA; Fong Y
FASEB J; 2014 Feb; 28(2):676-82. PubMed ID: 24186964
[TBL] [Abstract][Full Text] [Related]
16. Vaccinia virus-mediated intra-tumoral expression of matrix metalloproteinase 9 enhances oncolysis of PC-3 xenograft tumors.
Schäfer S; Weibel S; Donat U; Zhang Q; Aguilar RJ; Chen NG; Szalay AA
BMC Cancer; 2012 Aug; 12():366. PubMed ID: 22917220
[TBL] [Abstract][Full Text] [Related]
17. Efficient colonization and therapy of human hepatocellular carcinoma (HCC) using the oncolytic vaccinia virus strain GLV-1h68.
Gentschev I; Müller M; Adelfinger M; Weibel S; Grummt F; Zimmermann M; Bitzer M; Heisig M; Zhang Q; Yu YA; Chen NG; Stritzker J; Lauer UM; Szalay AA
PLoS One; 2011; 6(7):e22069. PubMed ID: 21779374
[TBL] [Abstract][Full Text] [Related]
18. Vaccinia virus GLV-1h153 is a novel agent for detection and effective local control of positive surgical margins for breast cancer.
Gholami S; Chen CH; Belin LJ; Lou E; Fujisawa S; Antonacci C; Carew A; Chen NG; De Brot M; Zanzonico PB; Szalay AA; Fong Y
Breast Cancer Res; 2013 Mar; 15(2):R26. PubMed ID: 23506710
[TBL] [Abstract][Full Text] [Related]
19. Vaccinia virus GLV-1h237 carrying a Walker A motif mutation of mouse Cdc6 protein enhances human breast tumor therapy in mouse xenografts.
Hofmann E; Grummt F; Szalay AA
Int J Oncol; 2011 Mar; 38(3):871-8. PubMed ID: 21249314
[TBL] [Abstract][Full Text] [Related]
20. Role of MAPK in oncolytic herpes viral therapy in triple-negative breast cancer.
Gholami S; Chen CH; Gao S; Lou E; Fujisawa S; Carson J; Nnoli JE; Chou TC; Bromberg J; Fong Y
Cancer Gene Ther; 2014 Jul; 21(7):283-9. PubMed ID: 24924199
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]